Summit Therapeutics's total assets for Q3 2025 were £261.73M, a decrease of ― from the previous quarter. SMMT total liabilities were £69.47M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.